Unknown

Dataset Information

SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1.


ABSTRACT:

Background

Endocrine therapy plays a key role in estrogen receptor-positive breast cancer patients; but, tamoxifen resistance could be a real difficulty for these patients. Several attempts have been made to explore the mechanism and new therapies for these patients. We intend to clarify the expression change of SRC and SIRT1 in tamoxifen-resistant breast cancer cells and explore their functions on tamoxifen resistance.

Methods

SRC and SIRT1 expressions were analyzed by RNA sequencing, qPCR and Western blotting. Loss and gain of function of SRC and SIRT1 were utilized to indicate their oncogenic roles in tamoxifen resistance in vitro and in vivo. Kaplan-Meier analysis and receiver operating characteristic curve were used to evaluate the survival and the predicted effects o

SUBMITTER: Zhou J 

PROVIDER: S-EPMC7259490 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature